As many as one in five American adults diagnosed with COVID-19 are affected by lingering effects of the disease. The Biden-Harris administration is working on understanding the causes of long COVID, which includes brain fog, fatigue, cough and shortness of breath. Long-term recovery rates for other conditions associated with increased risk of increased blood clots are associated with an impaired lung function. Drugs treating fibrotic lung disease and restrictive lung disease are currently undergoing clinical trials in the U.S.Read Long Article
